Renin‐Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID‐19

BACKGROUND: Considering the widespread risk of collider bias and confounding by indication in previous research, the associations between renin‐angiotensin aldosterone system (RAAS) inhibitor use and COVID‐19 remain unknown. Accordingly, this study tested the hypothesis that RAAS inhibitors influenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Loader, Jordan, Lampa, Erik, Gustafsson, Stefan, Cars, Thomas, Sundström, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475700/
https://www.ncbi.nlm.nih.gov/pubmed/34320843
http://dx.doi.org/10.1161/JAHA.120.021154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475700/
https://www.ncbi.nlm.nih.gov/pubmed/34320843
http://dx.doi.org/10.1161/JAHA.120.021154

Ejemplares similares